{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:51:33Z","timestamp":1772121093792,"version":"3.50.1"},"reference-count":98,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmdjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jmoldx.2021.11.005","type":"journal-article","created":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T21:16:50Z","timestamp":1640207810000},"page":"224-240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Distinct miRNA Expression Signatures of Primary and Secondary Central Nervous System Lymphomas"],"prefix":"10.1016","volume":"24","author":[{"given":"Endre","family":"Sebesty\u00e9n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6118-0365","authenticated-orcid":false,"given":"\u00c1kos","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00f3ra","family":"Marosv\u00e1ri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajnalka","family":"Rajnai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9la","family":"Kajt\u00e1r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Be\u00e1ta","family":"De\u00e1k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e1s","family":"Matolcsy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Brandner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6515-8381","authenticated-orcid":false,"given":"James","family":"Storhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attila G.","family":"Bag\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Csaba","family":"B\u00f6d\u00f6r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5593-7712","authenticated-orcid":false,"given":"Lilla","family":"Reiniger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2021.11.005_bib1","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1182\/blood-2005-03-1024","article-title":"A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases","volume":"107","author":"Camilleri-Broet","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib2","first-page":"5505","article-title":"Immunohistochemical profile and prognostic significance in primary central nervous system lymphoma: analysis of 89 cases","volume":"14","author":"Liu","year":"2017","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib3","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/neuonc\/noy192","article-title":"Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma","volume":"21","author":"Grommes","year":"2019","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib4","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1002\/acg2.82","article-title":"Primary central nervous system lymphoma: consensus, controversies, and future directions","volume":"3","author":"Hilal","year":"2020","journal-title":"Adv Cell Gene Ther"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib5","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib6","doi-asserted-by":"crossref","first-page":"9991","DOI":"10.1073\/pnas.1732008100","article-title":"A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma","volume":"100","author":"Wright","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11864-017-0449-1","article-title":"Molecular subtyping in diffuse large B cell lymphoma: closer to an approach of precision therapy","volume":"18","author":"Karmali","year":"2017","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib8","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.hoc.2016.07.001","article-title":"Molecular classification of diffuse large b-cell lymphoma: what is clinically relevant?","volume":"30","author":"Sujobert","year":"2016","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib9","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood-2013-11-536433","article-title":"Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue","volume":"123","author":"Scott","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib11","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0092-8674(03)01018-3","article-title":"Prediction of mammalian microRNA targets","volume":"115","author":"Lewis","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib12","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1371\/journal.pbio.0030085","article-title":"Principles of microRNA-target recognition","volume":"3","author":"Brennecke","year":"2005","journal-title":"PLoS Biol"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib13","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.3390\/ijms19103139","article-title":"MicroRNAs in autoimmunity and hematological malignancies","volume":"19","author":"Di Marco","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.blre.2013.04.002","article-title":"MicroRNAs in hematological malignancies","volume":"27","author":"Lawrie","year":"2013","journal-title":"Blood Rev"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib15","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/bjh.15547","article-title":"Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma","volume":"183","author":"Seto","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib16","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1038\/bcj.2013.49","article-title":"Role of microRNAs and microRNA machinery in the pathogenesis of diffuse large B-cell lymphoma","volume":"3","author":"Caramuta","year":"2013","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib17","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1365-2141.2008.07237.x","article-title":"MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas","volume":"142","author":"Roehle","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib18","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1182\/blood-2010-11-321554","article-title":"miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy","volume":"118","author":"Montes-Moreno","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib19","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1182\/blood-2014-04-566778","article-title":"Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma","volume":"125","author":"Iqbal","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib20","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1515\/cclm-2016-0471","article-title":"Variability in, variability out: best practice recommendations to standardize pre-analytical variables in the detection of circulating and tissue microRNAs","volume":"55","author":"Khan","year":"2017","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib21","first-page":"519","article-title":"MicroRNA expression profiling outperforms mRNA expression profiling in formalin-fixed paraffin-embedded tissues","volume":"2","author":"Liu","year":"2009","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib22","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/bjc.2012.294","article-title":"Enhanced stability of microRNA expression facilitates classification of FFPE tumour samples exhibiting near total mRNA degradation","volume":"107","author":"Hall","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib23","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1080\/14737159.2019.1623672","article-title":"Application of NanoString technologies in companion diagnostic development","volume":"19","author":"Eastel","year":"2019","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib24","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13742-015-0099-9","article-title":"Multi-platform microRNA profiling of hepatoblastoma patients using formalin fixed paraffin embedded archival samples","volume":"4","author":"Leichter","year":"2015","journal-title":"Gigascience"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib25","doi-asserted-by":"crossref","first-page":"e52517","DOI":"10.1371\/journal.pone.0052517","article-title":"Multi-platform analysis of microRNA expression measurements in RNA from fresh frozen and FFPE tissues","volume":"8","author":"Kolbert","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib26","doi-asserted-by":"crossref","first-page":"10438","DOI":"10.1038\/srep10438","article-title":"A cross comparison of technologies for the detection of microRNAs in clinical FFPE samples of hepatoblastoma patients","volume":"5","author":"Chatterjee","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib27","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1016\/j.celrep.2019.11.078","article-title":"Comparison of reproducibility, accuracy, sensitivity, and specificity of miRNA quantification platforms","volume":"29","author":"Godoy","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib28","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1182\/blood-2010-09-308684","article-title":"Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system","volume":"117","author":"Baraniskin","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/neuonc\/nor169","article-title":"Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma","volume":"14","author":"Baraniskin","year":"2012","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib30","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/neuonc\/nov144","article-title":"Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for primary central nervous system lymphoma","volume":"18","author":"Baraniskin","year":"2016","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib31","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s11060-018-2749-0","article-title":"MicroRNA-30c as a novel diagnostic biomarker for primary and secondary B-cell lymphoma of the CNS","volume":"137","author":"Baraniskin","year":"2018","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib32","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/neuonc\/nor107","article-title":"Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas","volume":"13","author":"Fischer","year":"2011","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib33","first-page":"3475","article-title":"Role of miRNA-21 in the diagnosis and prediction of treatment efficacy of primary central nervous system lymphoma","volume":"17","author":"Yang","year":"2019","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib34","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10072-013-1491-9","article-title":"Serum miR-21 is a diagnostic and prognostic marker of primary central nervous system lymphoma","volume":"35","author":"Mao","year":"2014","journal-title":"Neurol Sci"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib35","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ejca.2014.10.028","article-title":"Differentially regulated miRNAs as prognostic biomarkers in the blood of primary CNS lymphoma patients","volume":"51","author":"Roth","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib36","doi-asserted-by":"crossref","first-page":"e0210400","DOI":"10.1371\/journal.pone.0210400","article-title":"MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma","volume":"14","author":"Takashima","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib37","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/modpathol.2009.10","article-title":"Specific expression of miR-17-5p and miR-127 in testicular and central nervous system diffuse large B-cell lymphoma","volume":"22","author":"Robertus","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib38","doi-asserted-by":"crossref","first-page":"20829","DOI":"10.18632\/oncotarget.4096","article-title":"A differentially expressed set of microRNAs in cerebro-spinal fluid (CSF) can diagnose CNS malignancies","volume":"6","author":"Drusco","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib39","first-page":"2048","article-title":"Clinicopathological study of gene rearrangement and microRNA expression of primary central nervous system diffuse large B-cell lymphomas","volume":"6","author":"Zheng","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib40","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/jnen\/nlz125","article-title":"Molecular subtypes and genomic profile of primary central nervous system lymphoma","volume":"79","author":"Bodor","year":"2020","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib41","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma Powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib42","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/gb-2014-15-2-r29","article-title":"voom: Precision weights unlock linear model analysis tools for RNA-seq read counts","volume":"15","author":"Law","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib43","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1214\/16-AOAS920","article-title":"Robust hyperparameter estimation protects against hypervariable genes and improves power to detect differential expression","volume":"10","author":"Phipson","year":"2016","journal-title":"Ann Appl Stat"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib44","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/978-1-4939-8618-7_10","article-title":"miRNet-functional analysis and visual exploration of miRNA-target interactions in a network context","volume":"1819","author":"Fan","year":"2018","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib45","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib46","doi-asserted-by":"crossref","first-page":"e1008273","DOI":"10.1371\/journal.pgen.1008273","article-title":"BCDIN3D regulates tRNAHis 3' fragment processing","volume":"15","author":"Reinsborough","year":"2019","journal-title":"PLoS Genet"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib47","doi-asserted-by":"crossref","first-page":"e7952","DOI":"10.1097\/MD.0000000000007952","article-title":"Effects of microRNA-21 on apoptosis by regulating the expression of PTEN in diffuse large B-cell lymphoma","volume":"96","author":"Song","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib48","first-page":"15019","article-title":"miR-21 expression predicts prognosis in diffuse large B-cell lymphoma","volume":"8","author":"Li","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib49","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nature03552","article-title":"A microRNA polycistron as a potential human oncogene","volume":"435","author":"He","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib50","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1038\/sj.leu.2403942","article-title":"A microRNA cluster as a target of genomic amplification in malignant lymphoma","volume":"19","author":"Tagawa","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib51","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1182\/blood-2012-12-473090","article-title":"The Myc-miR-17-92 axis amplifies B-cell receptor signaling via inhibition of ITIM proteins: a novel lymphomagenic feed-forward loop","volume":"122","author":"Psathas","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib52","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1158\/1078-0432.CCR-11-0224","article-title":"MicroRNAs are independent predictors of outcome in diffuse large B-cell lymphoma patients treated with R-CHOP","volume":"17","author":"Alencar","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib53","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13059-014-0568-y","article-title":"Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients","volume":"16","author":"Lim","year":"2015","journal-title":"Genome Biol"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib54","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3892\/etm.2012.502","article-title":"Clinical and prognostic significance of miR-155 and miR-146a expression levels in formalin-fixed\/paraffin-embedded tissue of patients with diffuse large B-cell lymphoma","volume":"3","author":"Zhong","year":"2012","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib55","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1073\/pnas.0500613102","article-title":"Accumulation of miR-155 and BIC RNA in human B cell lymphomas","volume":"102","author":"Eis","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib56","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ajpath.2012.03.013","article-title":"Quantitative proteomics reveals that miR-155 regulates the PI3K-AKT pathway in diffuse large B-cell lymphoma","volume":"181","author":"Huang","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib57","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.canlet.2013.01.005","article-title":"PRDM1 is directly targeted by miR-30a-5p and modulates the Wnt\/beta-catenin pathway in a Dkk1-dependent manner during glioma growth","volume":"331","author":"Wang","year":"2013","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib58","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ccr.2013.12.012","article-title":"SnapShot: diffuse large B cell lymphoma","volume":"25","author":"Pasqualucci","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib59","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1182\/blood-2014-05-577189","article-title":"Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity","volume":"125","author":"Sehn","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib60","first-page":"989","article-title":"Precision medicine in diffuse large B-cell lymphoma: hitting the target","volume":"100","author":"Vermaat","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib61","doi-asserted-by":"crossref","first-page":"27471","DOI":"10.18632\/oncotarget.25463","article-title":"Target amplicon exome-sequencing identifies promising diagnosis and prognostic markers involved in RTK-RAS and PI3K-AKT signaling as central oncopathways in primary central nervous system lymphoma","volume":"9","author":"Takashima","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib62","first-page":"55","article-title":"Evaluation of DNA extraction methods and real time PCR optimization on formalin-fixed paraffin-embedded tissues","volume":"8","author":"Dedhia","year":"2007","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib63","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1471-2199-8-118","article-title":"RNA extraction from ten year old formalin-fixed paraffin-embedded breast cancer samples: a comparison of column purification and magnetic bead-based technologies","volume":"8","author":"Ribeiro-Silva","year":"2007","journal-title":"BMC Mol Biol"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib64","first-page":"797","article-title":"Excavation of a buried treasure--DNA, mRNA, miRNA and protein analysis in formalin fixed, paraffin embedded tissues","volume":"26","author":"Klopfleisch","year":"2011","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib65","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.1093\/nar\/27.22.4436","article-title":"Analysis of chemical modification of RNA from formalin-fixed samples and optimization of molecular biology applications for such samples","volume":"27","author":"Masuda","year":"1999","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib66","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/bio.2012.0052","article-title":"Archived formalin-fixed paraffin-embedded (FFPE) blocks: a valuable underexploited resource for extraction of DNA, RNA, and protein","volume":"11","author":"Kokkat","year":"2013","journal-title":"Biopreserv Biobank"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib67","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/14789450.2019.1615452","article-title":"Update on proteomic studies of formalin-fixed paraffin-embedded tissues","volume":"16","author":"Giusti","year":"2019","journal-title":"Expert Rev Proteomics"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib68","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3389\/fimmu.2018.00936","article-title":"The function of microRNAs in B-cell development, lymphoma, and their potential in clinical practice","volume":"9","author":"Zheng","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib69","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrc1840","article-title":"Oncomirs - microRNAs with a role in cancer","volume":"6","author":"Esquela-Kerscher","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib70","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib71","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.7150\/jca.38449","article-title":"Role of MicroRNA-30c in cancer progression","volume":"11","author":"Han","year":"2020","journal-title":"J Cancer"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib72","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1042\/BST0370918","article-title":"miR-21 as a key regulator of oncogenic processes","volume":"37","author":"Selcuklu","year":"2009","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib73","first-page":"4489","article-title":"MicroRNA-21 regulates the viability and apoptosis of diffuse large B-cell lymphoma cells by upregulating B cell lymphoma-2","volume":"14","author":"Liu","year":"2017","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib74","first-page":"334","article-title":"miR-4284 and miR-4484 as putative biomarkers for diffuse large B-cell lymphoma","volume":"41","author":"Tamaddon","year":"2016","journal-title":"Iran J Med Sci"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib75","doi-asserted-by":"crossref","first-page":"15035","DOI":"10.18632\/oncotarget.3729","article-title":"MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K\/AKT pathway in diffuse large B-cell lymphoma","volume":"6","author":"Go","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib76","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/ijc.22800","article-title":"MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma","volume":"121","author":"Lawrie","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib77","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1582-4934.2008.00628.x","article-title":"Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma","volume":"13","author":"Lawrie","year":"2009","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib78","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1200\/EDBK_200829","article-title":"Treatment of primary central nervous system lymphoma: from chemotherapy to small molecules","volume":"38","author":"Mendez","year":"2018","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/boc.201800050","article-title":"The role of the unfolded protein response in cancer progression: from oncogenesis to chemoresistance","volume":"111","author":"Madden","year":"2019","journal-title":"Biol Cell"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib80","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1093\/annonc\/mdx515","article-title":"Secondary CNS lymphoma: the poisoned needle in the haystack","volume":"28","author":"Ferreri","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib81","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1158\/2159-8290.CD-17-0613","article-title":"Ibrutinib unmasks critical role of bruton tyrosine kinase in primary CNS lymphoma","volume":"7","author":"Grommes","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib82","article-title":"Idelalisib in relapsed\/refractory diffuse large B-cell lymphoma: results from a Nordic Lymphoma Group phase II trial","author":"Fjorden","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib83","doi-asserted-by":"crossref","first-page":"e636","DOI":"10.1097\/HS9.0000000000000636","article-title":"The mTOR inhibitor temsirolimus added to rituximab combined with dexamethasone, cytarabine, and cisplatinum (R-DHAP) for the treatment of patients with relapsed or refractory DLBCL - results from the phase-II STORM trial","volume":"5","author":"Witzens-Harig","year":"2021","journal-title":"Hemasphere"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib84","doi-asserted-by":"crossref","DOI":"10.1177\/2040620719898373","article-title":"WEE1 inhibition synergizes with CHOP chemotherapy and radiation therapy through induction of premature mitotic entry and DNA damage in diffuse large B-cell lymphoma","volume":"11","author":"de Jong","year":"2020","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib85","doi-asserted-by":"crossref","first-page":"6029","DOI":"10.1158\/0008-5472.CAN-21-1023","article-title":"Inhibition of PIM kinases in DLBCL targets MYC transcriptional program and augments the efficacy of anti-CD20 antibodies","volume":"81","author":"Szydlowski","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21775\/cimb.031.001","article-title":"Hypothesis of opposite interplay between the canonical WNT\/beta-catenin pathway and PPAR gamma in primary central nervous system lymphomas","volume":"31","author":"Vallee","year":"2019","journal-title":"Curr Issues Mol Biol"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib87","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.2174\/1871520619666190925143216","article-title":"Signal pathways and therapeutic prospects of diffuse large B cell lymphoma","volume":"19","author":"Sun","year":"2019","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib88","first-page":"7340","article-title":"FBN1 promotes DLBCL cell migration by activating the Wnt\/beta-catenin signaling pathway and regulating TIMP1","volume":"12","author":"Wang","year":"2020","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib89","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/s41375-019-0404-1","article-title":"Aberrant Wnt signaling in multiple myeloma: molecular mechanisms and targeting options","volume":"33","author":"van Andel","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib90","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1073\/pnas.0308648100","article-title":"Activation of the Wnt signaling pathway in chronic lymphocytic leukemia","volume":"101","author":"Lu","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib91","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1182\/blood-2008-02-139212","article-title":"Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma","volume":"112","author":"Gelebart","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib92","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00005-008-0029-y","article-title":"Role of the Wnt\/beta-catenin network in regulating hematopoiesis","volume":"56","author":"Wilusz","year":"2008","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib93","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/jcb.22467","article-title":"Wnt signaling in hematopoiesis: crucial factors for self-renewal, proliferation, and cell fate decisions","volume":"109","author":"Staal","year":"2010","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib94","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1756-8722-3-33","article-title":"Role of Wnt canonical pathway in hematological malignancies","volume":"3","author":"Ge","year":"2010","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib95","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/cas.12655","article-title":"Targeting the canonical Wnt\/beta-catenin pathway in hematological malignancies","volume":"106","author":"Ashihara","year":"2015","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib96","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s12276-020-0380-6","article-title":"Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond beta-catenin and the destruction complex","volume":"52","author":"Jung","year":"2020","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib97","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13045-020-00990-3","article-title":"Targeting the Wnt\/beta-catenin signaling pathway in cancer","volume":"13","author":"Zhang","year":"2020","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jmoldx.2021.11.005_bib98","doi-asserted-by":"crossref","first-page":"9026","DOI":"10.3390\/ijms21239026","article-title":"Targeting casein kinase 1 (CK1) in hematological cancers","volume":"21","author":"Janovska","year":"2020","journal-title":"Int J Mol Sci"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152515782100427X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152515782100427X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:16:31Z","timestamp":1761502591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152515782100427X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":98,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S152515782100427X"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2021.11.005","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.02.05.21249862","asserted-by":"object"}]},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinct miRNA Expression Signatures of Primary and Secondary Central Nervous System Lymphomas","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2021.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}